BCL9 Antikörper (AA 231-340)
-
- Target Alle BCL9 Antikörper anzeigen
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Bindungsspezifität
- AA 231-340
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human B-cell CLL/lymphoma 9 protein (231-340AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
- Andere Bezeichnung
- BCL9 (BCL9 Produkte)
- Synonyme
- lgs antikoerper, xbcl9 antikoerper, legless antikoerper, MGC83888 antikoerper, BCL9 antikoerper, 2610202E01Rik antikoerper, 8030475K17Rik antikoerper, A330041G23Rik antikoerper, Gm130 antikoerper, LGS antikoerper, B-cell CLL/lymphoma 9 L homeolog antikoerper, B-cell CLL/lymphoma 9 antikoerper, B cell CLL/lymphoma 9 antikoerper, bcl9.L antikoerper, BCL9 antikoerper, Bcl9 antikoerper
- Hintergrund
-
Background: Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity).
Aliases: BCL9B-cell CLL/lymphoma 9 protein antibody, B-cell lymphoma 9 protein antibody, Bcl-9 antibody, Protein legless homolog antibody
- UniProt
- O00512
- Pathways
- Stem Cell Maintenance
-